Orion Oyj Q2 Surges: 25% Revenue Growth, Up‑Rised Profit Forecast, and Strong Investor Momentum
Orion Oyj’s Q2 beats expectations, driving revenue +25% and margin to 33.9%. The company lifts its 2026 profit outlook, positioning itself as a resilient, growth‑oriented pharma player.
3 minutes to read